{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-043276","form_type":"8-K","ticker":"CRBP","cik":"0001595097","company_name":"Corbus Pharmaceuticals Holdings, Inc.","filed_at":"2025-03-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.112085+00:00","generated_at":"2026-05-24T08:42:27.694479+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Director Peter Salzmann not standing for re-election; board size reduced to seven","bullets":["Dr. Salzmann will not stand for re-election at the 2025 annual meeting.","He continues as director and Nominating and Governance Committee member until the meeting.","Decision was not due to any disagreement with the company.","Board size reduced from eight to seven effective after the annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-043276","json":"https://secwatch.observer/filing/0000950170-25-043276.json","markdown":"https://secwatch.observer/filing/0000950170-25-043276.md","text":"https://secwatch.observer/filing/0000950170-25-043276.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025043276/0000950170-25-043276-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025043276/crbp-20250320.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T08:42:27.694479+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c79994fdd0","claim":"Peter Salzmann departed as Director at Corbus Pharmaceuticals Holdings, Inc..","evidence_excerpt":"Dr. Peter Salzmann advised the Board of Directors (the “Board”) of Corbus Pharmaceuticals Holdings, Inc. (the “Company”) that he will not stand for re-election as a director of the Company at the 2025 annual meeting of stockholders (the “2025 Annual Meeting”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025043276/0000950170-25-043276-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will not stand for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}